Friday, 13 Jul 2018

You are here

The Cost of Not Taking Medicine

The NY Times points out "there is is an out-of-control epidemic in the United States that costs more and affects more people than any disease Americans currently worry about. It’s called nonadherence to prescribed medications, and it is — potentially, at least — 100 percent preventable by the very individuals it afflicts.

Studies show at least 20% up to 50% percent of prescriptions are never filled.

Nearly 50% of medications for chronic disease are not taken as prescribed.

A recent Annals of Internal Medicine article estimated that nonadherence resulted in approximately 125,000 deaths and at least 10 percent of hospitalizations; costing US health care system $100 - 289 billion a year.

Other studies have shown 1/3 of kidney transplant patients don’t take their anti-rejection medications, and 41 percent of heart attack patients don’t take their blood pressure medications.

Patients don't like to take medicine and taking them "reminds them.. they’re sick".

Other don't take them because of cost, complicated regimens, fear of side effects and other social issues. 

It is not enough to prescribe the right drug to the right patient.  Physicians have to build trust with their patients, and in doing so will allow for more effective communication on the need for the meds they prescribe. 

 

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Best of 2017: New EULAR Guidelines on Behçet's

At the EULAR 2016 meeting, new EULAR recommendations for the management of Behçet's disease (BD) were presented. These were developed by a multidisciplinary expert committee that reviewed the evidence from the medical literature and developed final set of 9 recommendations:

EULAR 2018 - Day 3 Report

Day 3 highlights include Behcet’s responds to apremilast and that biologics do not differentially affect TKR/THR post-operative infection rates. Be sure to check out today's podcast as well. 

Canada Closer to Marijuana Approval

Reuters reports that Canada’s Senate on Thursday voted to legalize recreational marijuana, clearing a major hurdle that puts the country on track to become the first Group of Seven nation to permit national use of the drug.

Now the law and amendments go to the House of Commons who will need to decide on before the law can be passed.

Advance Practice Clinicians Proliferating in Specialty Practices

An analysis of SK&A outpatient provider files, covering 90% of physician practices in the United States, shows that between 2008 to 2016, there was a 22% increase in the employment of advanced practice clinicians (APCs) by specialty practices.  By 2016, 28% of all specialty practices employed APCs.

Trump Blasts Drug Makers on the Price of Drugs

Reuter's reports Friday that President Donald Trump blasted drugmakers and healthcare “middlemen” for making prescription drugs unaffordable for Americans. Nonetheless, many healthcare stocks rose as it became clear the administration had avoided taking aggressive and direct measures to cut drug prices.

Here are many New Sources on this developing story: